AstraZeneca is headquartered in Cambridge in the UK, with major operations in Sodertalje, Sweden, and focuses on oncology, cardiovascular, respiratory and rare diseases. Its cancer drugs include Tagrisso for lung cancer and Imfinzi in immunotherapy, and it co-developed the Oxford-AstraZeneca COVID-19 vaccine.
The company faces patent expirations and strong competition in lung-cancer and diabetes treatments.